Mackenzie Financial
AMAG

Mackenzie Financial’s AMAG Pharmaceuticals AMAG Stock Holding History

Mackenzie Financial’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-20,741
Closed -$626K – 908
2015
Q4 		$626K Sell
20,741
-41,011
-66% -$1.32M ﹤0.01% 620
2015
Q3 		$2.45M Buy
61,752
+10,240
+20% +$636K 0.01% 385
2015
Q2 		$3.56M Buy
51,512
+26,771
+108% +$1.68M 0.02% 348
2015
Q1 		$1.35M Buy
24,741
+6,252
+34% +$298K 0.01% 495
2014
Q4 		$788K Buy
18,489
+389
+2% +$14.1K ﹤0.01% 577
2014
Q3 		$578K Buy
+18,100
New +$386K ﹤0.01% 603

Other funds holding AMAG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SIM
Stelliam Investment Management New York $404M AUM 5.1% 1-Year Est. Return

Mackenzie Financial's AMAG Position: Q1 2016 in Review

Mackenzie Financial sold out of AMAG Pharmaceuticals (AMAG) in Q1 2016, closing a stake of 20,741 shares — an estimated $626K sold.

Mackenzie Financial first reported a position in AMAG in Q3 2014 and held it in 6 quarters. The position peaked at $3.56M in Q2 2015. 185 funds tracked by Wall St. Rank hold AMAG as of Q1 2016.

  • Mackenzie Financial reported no remaining AMAG Pharmaceuticals position as of Q1 2016 after selling out during the quarter.
  • Mackenzie Financial sold 20,741 AMAG Pharmaceuticals shares in Q1 2016, an estimated $626K.
  • Mackenzie Financial first reported a position in AMAG Pharmaceuticals in Q3 2014 and held it in 6 quarters.
  • Mackenzie Financial's AMAG Pharmaceuticals position peaked at $3.56M in Q2 2015.
  • 185 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q1 2016.

Based on Mackenzie Financial's 13F filing for Q1 2016, filed 12 May 2016.